baber/WOPTO huggingface dataset:
Patent PT-797396-E (PT)
Inventor: GARBIT BERNARD PIERRE-MARIE
IPC: A41D23/00
Filed: 1995-12-13
Abstract: PCT No. PCT/FR95/01658 Sec. 371 Date Aug. 11, 1997 Sec. 102(e) Date Aug. 11, 1997 PCT Filed Dec. 13, 1995 PCT Pub. No. WO96/18316 PCT Pub. Date Jun. 20, 1996The ball scarf is a scarf having a first end and a second end. At least one of the ends has an inflatable ball pocket. The inflatable ball pocket can either have an inflatable bladder inserted therein or an inflatable ball inserted therein. Once the pocket is inflated by a user, the user can swing the ball scarf around in order to cheer his favorite team at a ball game. A needle is provided in order to inflate the inflatable bladder or inflatable ball. The inflatable ball pocket is either an integral part of the scarf or can be attached by means of a zipper or other fastener.
Patent PT-842193-E (PT)
Inventor: DEGHENGHI ROMANO
IPC: A61P5/00
Filed: 1996-07-17
Abstract: PCT No. PCT/EP96/03149 Sec. 371 Date Jan. 14, 1998 Sec. 102(e) Date Jan. 14, 1998 PCT Filed Jul. 17, 1996 PCT Pub. No. WO97/05167 PCT Pub. Date Feb. 13, 1997Cyclic peptides of general formula (I), wherein the groups are as described in the disclosure, having inhibitory activity on growth hormone. The peptides of formula (I) have also anticancer activity.
Patent PT-871894-E (PT)
Inventor: MACK MICHAEL
IPC: G01N35/10
Filed: 1996-10-30
Abstract: PCT No. PCT/EP96/04705 Sec. 371 Date Jun. 29, 1998 Sec. 102(e) Date Jun. 29, 1998 PCT Filed Oct. 30, 1996 PCT Pub. No. WO97/16734 PCT Pub. Date May 9, 199752350626 The invention concerns a modular reagent cartridge (10) which includes a plurality of reagent containers (12 to 18) directly interconnected by integrally formed coupling devices (22). The connection is brought about by form-locking rail guides.
Patent PT-914344-E (PT)
Inventor: SCARDINA JAN MARIAN
IPC: C12N15/02
Filed: 1997-03-04
Abstract: The invention relates to an  in vitro  method of diagnosing congestive heart disease by quantifying hBNP in a sample. The method comprises: contacting a sample of the biological fluid with a first antibody, wherein the first antibody is monospecifically reactive to an hBNP fragment; forming a complex comprising hBNP in the biological fluid, the first antibody and a second antibody, wherein the second antibody is immunoreactive with hBNP or the first antibody, and wherein the second antibody comprises a label; and determining the amount of hBNP in the sample by quantifying the label in the complex.
Patent PT-1021556-E (PT)
Inventor: SWARTZ JAMES R
IPC: C12P21/00
Filed: 1997-10-10
Abstract: Presence of a contaminating microbial host cell (A), in a culture vessel containing a different host cell (B) able to use more than one carbohydrate (I), is detected by: (a) culturing (B), which includes nucleic acid encoding a particular polypeptide (II) and genetically marked so that it can not use a selected (I), (Ia), as substrate; (b) plating an isolated sample of the culture on a medium supplemented by (Ia); (c) incubating the plated cells, and (d) detecting if any colonies grow in the (Ia)-containing medium. Optionally (A) that grow in the supplemented medium may be plated on a field of different (I) to identify them from their specific (I)-utilising characteristics. The cells are yeasts or prokaryotes, particularly Gram-negative bacteria and specifically E. coli. They express an exogenous (II) and utilise e.g. maltose, ribose or rhamnose. (B) is genetically marked by making (a) a non-reversing, non-suppressing alteration in its genotype, in which case the sample is not diluted before plating or (b) a genotypic alteration that results in a carbohydrate utilisation revertant or suppressant, in which case the sample is serially diluted before plating. Optionally the strain is doubly marked by altering two (I)-utilisation pathways; (i) one type (a), in ribose utilisation and the other a reverting or suppressing mutation in rhamnose utilisation or (ii) both type (a), in maltose and ribose utilisation. Where two alterations are present, two plates are used in step (b), each supplemented with different (I). The vessel is a fermentor containing, before dilution, 108-1011 colony-forming units (cfu)/ml.
Patent PT-902013-E (PT)
Inventor: SCHROMM KURT
IPC: A61P11/06
Filed: 1993-01-14
Abstract: Amidine derivs. of formula (I), in the form of their racemates, enantiomer pure or enriched forms, diastereomer pairs, cis- and trans-isomers, free bases or salts (pref. with physiologically acceptable acids) are new. In (I), R1 and R2 are each CF3, halogen, R5, OR5, COR6, SR6, SOR6, SO2R6, SO2NR5R7, C(OH)R5R7, or R1 and R2 connect neighbouring C atoms on the benzene ring to which they are attached with -CR8=CR9CH=CH-, -CH=CR8CR9=CH-, -CR8=CHCR9=CH-, -OCHR10CH2-, -OCH2O-, -OCH2CH2O-, -(CH2)3-4-, -NHCOO-, -NHCOCH2O-, -COCH2O- or -COCH2CH2O-, each of these gps. being opt. substd. with 1-4C alkyl; R3 is H, OH, CF3, R5, OR6, COR6, CONR5R7, CH2OH, CH2O(1-4C alkyl), SR6, SOR6, SO2R6, SO2NR5R7, NHCO(1-4C alkyl), NHSO2(1-4C alkyl), NR5R7 or C(OH)R5R7 or a heterocyclic 5-ring contg. 1-3 heteroatoms and of formulae (a), (b) or (c); provided that if R3 is R5, R5 can only be H if at least one of R1 and R2 is not H; D, E and G are each CH, N, C(1-4C alkyl) or C-Ph; L is O or S; R4 is halogen, NH2, NH(1-4C alkyl), N(1-4C alkyl)2, OH, 1-4C alkoxy; R5 is H, 1-12C alkyl, phenyl(1-4C)alkyl or Ph (opt. substd. with halogen, 1-4C alkyl, 1-4C alkoxy or 2-5C acyl); R6 is 1-12C alkyl, Ph (opt. substd. with halogen, 1-4C alkyl, 1-4C alkoxy or 2-5C acyl); R7 is H or 1-12C alkyl; R8 and R9 are each H, OH, 1-4C alkyl, 1-4C alkoxy or 2-5C acyl; R10 is H or 1-4C alkyl; R11 and R12 are each H, OH, halogen, CF3, 1-4C alkyl or 1-4C alkoxy; A is (d), (e), X1A1X2, X2A2X3, X4A2X2, (CH2)1-2NHCO(CH2)1-3X2, -CH=CHA2X2; B is CH=CH, CH=N, S or (f); A1 is 2-4C alkylene, cis- or trans-CH2CH=CHCH2, CH2CCCH2, etc.; A2 is 1-5C alkylene; X1 is O, NH, S, SO, SO2, CO, CH2 or a gp. of formula (d); X2 is O, NH, S or a gp. of formula (e); X3 is NHCO, CONH, SO2NH or a gp. of formula (d); X4 is NHCO, CONH, NHSO2, SO2NH or NHCONH.
Patent PT-993583-E (PT)
Inventor: MOREAU ANDRE
IPC: F23N1/00
Filed: 1998-06-30
Abstract: The invention concerns a tap comprising a rod (6) adjusting the gas flow rate arranged inside a bore (18) of the tap body (4), comprising a cavity (80) communicating axially with a first gas passage (30), and laterally with an orifice 838) formed through the bore side wall, at the end of a second gas passage (36). The area of coincidence between the orifice (38) and a lateral opening (84) of the rod varies continuously and gradually during the rotation of the rod inside the bore. A thrust bearing (14) axially adjustable by means of a certain compressibility of its fixing tab (108) enables to calibrate the tap while it is being manufactured. The invention is applicable to taps for gas appliances.
Patent PT-986981-E (PT)
Inventor: FUMAGALLI CRISTIANO
IPC: A47G1/14
Filed: 1999-09-13
Abstract: A back (1) for picture frames and the like with elements for adapting to different sizes, comprising a back body (2) to which a supporting leg (3) is connected by hinge means (4), the back further comprising elements (10) for continuous sliding in order to vary without discontinuity the placement of said hinge means (4) with respect to said back body (2). <IMAGE>
Patent PT-999240-E (PT)
Inventor: EDEN BIRGIT
IPC: C09B67/22
Filed: 1999-11-04
Abstract: Dyestuff mixtures of at least one dye of formula (Ia) or (Ib) and at least one dye of formula (IIa), (IIb) or (IIc) are used for yellow dyeing of OH- and carbonamide group-containing materials, especially fibers. Dyestuff mixtures comprise one or more dyes of formula (Ia) and/or (Ib) and one or more dyes of formula (IIa) and/or (IIb) and/or (IIc) in a molar ratio (Ia) and/or (Ib) to (IIa) and/or (IIb) and/or (IIc) of 70:30 to 30:70. M = H or alkali metal; D = a residue of the benzene or naphthalene series; Y<1> = vinyl or ethyl which is substituted in the  beta -position by a substituent which is eliminated under alkaline conditions; R = amino or 1-4 C alkyl or 1-4 C alkyl substituted by carboxy, sulfo, phosphato, OH or -SO2Y<2>; Y<2> = as for Y<1>: R<1> = H, 1-4 C alkyl, 1-4 C alkoxy or sulfo; m = 1, 2 or 3; Z = a fiber-reactive residue selected from halopyrimidine, dichloroquinoxaline or optionally ether- or amino group-substituted halotriazine series, where the halotriazine residue may also be bonded to a group of formula -SO2-Y<3> which is bonded to the amino group bound to the triazine residue via a bridging member; Y<3> = as for Y<1>; Zo = a bivalent group of formula (III); Hal = Cl or F; W = phenylene, alkylene, phenylene-alkylene-phenylene or phenylene-phenylene or a residue of general formula phenylene-G-phenylene, in which the phenylene residues are optionally substituted by 1 or 2 substituents selected from OMe, OEt, Me, Et, sulfo or carboxy, the alkyl residues have 1-6 C and may be substituted by sulfo or carboxy and/or may be interrupted by 1 or 2 heteroatoms, and the alkylene residues have 2-4 C; G = -O-, -NH-, -CO- or -NH-CO-NH; R<2> = Me or carboxy; R<3> = H, halogen, 1-4 C alkyl or 1-4 C alkoxy; p, q = 0 ,1 or 2; and (p+q) = 1, 2 or 3. If p = 0 or q = 0 then M = H. In (IIa) the group -NH-Z may be bound to benzene ring A or benzene ring B. In (IIb) one amino group of the bridging member -NH-Zo-NH- is bound to benzene ring A of one monoazo residue and the other amino group to benzene ring B of the other monoazo residue, or the two amino groups may both be bound to A or to B. R<4>, R<6>, R<7> = H, sulfo, 1-4 C alkyl or 1-4 C alkoxy; R<5> = Me or carboxy; n = 1 or 2; and B<0> = H when n = 1, or when n = 2, Bo = a direct covalent bond, alkylene, alkenylene or alkylene-phenylene-alkylene, in which the phenylene residues are optionally substituted with 1 or 2 substituents selected from OMe, OEt, Me, Et, sulfo and carboxy, the alkylene groups have 1-6 C and may be substituted by sulfo or carboxy and/or interrupted by 1 or 2 hetero groups and the alkenylene residues have 2-4 C, or is a residue as described above for Zo.
Patent SG-21492-G (SG)
Title: Distributing and dosing device
IPC: A21C9/04
Filed: 1992-03-04
Abstract: An apparatus for distributing and metering a granular and sticky mass, in particular a mass to be moulded into biscuits. The apparatus comprises a main conveyor device comprising juxtaposed parallel screws of alternate pitch and direction of rotation, which are sub-divided into groups of at least one pair of screws, a main motor and main transmission means comprising one clutch per group of screws, hoppers which are juxtaposed below the downstream end of the main conveyor device in a ratio of one hopper per group of screws and, beneath each hopper, a distribution column comprising an inlet, a holding chamber and an outlet, the said inlet being provided with a device for measuring the level of filling which is electronically connected to a control device for controlling the clutch of the said group of screws.
Patent SG-57492-G (SG)
Title: Clamp for connecting form work panels together
IPC: E04G17/04
Filed: 1992-06-01
Abstract: PCT No. PCT/DE89/00658 Sec. 371 Date May 13, 1991 Sec. 102(e) Date May 13, 1991 PCT Filed Oct. 18, 1989 PCT Pub. No. WO90/05225 PCT Pub. Date May 17, 1990.A clamp for connecting a pair of formwork panels which are to be disposed side-by-side in a common plane has two clamping members. Each of the clamping members includes a clamping arm for urging the panels together and an adjusting arm which is approximately perpendicular to the respective clamping arm. The clamping members are pivotally mounted on a U-shaped support and the adjusting arms are disposed internally of the support with their free ends overlapping. The clamping arms project from the support and are located on the same side of the latter as the transverse web bridging the legs of the support. The legs are provided with registering openings which are elongated transversely of the adjusting arms. A pivot extends through the overlapping ends of the adjusting arms and into the openings. The pivot is guided by the openings for movement transversely of the adjusting arms and carries an eccentric disc which is arranged to bear against the transverse web of the support. An actuating lever for the clamping members is integral with the disc and projects from the support approximately perpendicular to the clamping arms.
Patent SG-83391-G (SG)
Title: Crosslinkable chemical formulation and composite semipermeable membrane made therewith
IPC: C08L81/02
Filed: 1991-10-11
Abstract: A Composite semipermeable membrane comprises:
  (a) a flexible film of microporous polytetrafluoroethylene or other hydrophobic material having a water vapour transmission rate in excess of 10,000 g/m<2> - 24 hours, preferably above 100,000 g/m<2> . 24 hours, and an advancing water contact angle exceeding 90 degrees, and
 (b) a continuous. crosslinked amorphous hydrophilic layer preferably of polyoxyethylene polythioether penetrated to an extent into the face of the hydrophobic layer. The hydrophilic layer provides a composite membrane having a water vapour transmission rate of the complete ensemble comparable to or even exceeding that of the hydrophobic material alone, and simultaneously offering two mechanisms of separation; that imposed by the microporous hydrophobic material and that imposed by the hydrophilic layer, and as such is capable of numerous separation operations. The crosslinkable and crosslinked hydrophilic polyoxyethylene polythioether materials are new chemical formulations.
Patent SG-87191-G (SG)
Title: Conditioning hair shampoo compositions
IPC: A61K8/46
Filed: 1991-10-18
Abstract: Shampoos are disclosed which comprise a synthetic anionic surfactant, a dispersed, insoluble, non-volatile silicone, a xanthan gum suspending agent and water.
Patent IE-33109-L (IE)
Title: Pharmaceutical preparation
IPC: A61K45/06
Filed: 1969-01-02
Abstract: 1,225,830. Anti-psoriasis compositions. CIBA Ltd. 31 Dec., 1968 [8 Jan., 1968], No. 61909/ 68. Heading A5B. Pharmaceutical preparations, e.g. ointments, creams, pastes, foams, lotions and aerosol sprays, for the treatment of psoriasis, contain a dermatologically active steroid, and a triester of dithranol (1,8,9-trihydroxyanthracene) with a C 1-6 alkanoic acid unsubstituted or substituted by halogen and/or C 1-6 alkyl, in admixture or conjunction with a pharmaceutically suitable carrier. Triacetyldithranol is preferred. Suitable steroids include hydrocortisone, prednisolone, fluocortolone, fluorohydrocortisone, dexamethasone, betamethasone, triamcinoline and its acetonide, fluorometholone, 3, 20-dioxo- 6-fluoro-11, 16, 17, 21-tetrahydroxypregna-#<SP>4</SP>- en-16, 17-acetonide, fluocinolone acetonide and flumethasone or their esters with alkanecarboxylic acids or with inorganic acids, e.g. phosphoric or sulpuric acid, such as flumethasone pivalate. The preparations may also contain a keratolytic, e.g. salicyclic acid, antibiotics, antimycotics or antiseptics.
Patent CU-20864-L (CU)
Title: Metodo de fraccionamiento cromatografico en columna par a el aislamiento y purificacion de inmunoglobulinas
Inventor: DORTA CONTRERA ALBERTO
IPC: B01D15/08
Filed: 1975-08-18
Abstract: Obtención de un método de fraccionamiento cromatográfico mixto de intercambio-filtración, usando en una misma columna dos soportes diferentes, el ( Sephadex G-2) y ( DE-32 microgranular) el cual permite la purificación de inmunoglobulinas con: Incremento de la capacidad selectiva del intercambio. Ahorro del material a utilizar el cual constituye un renglón de importación. Utilización de columnas de menor longitud.
Patent IE-890519-L (IE)
Title: Novel compounds
IPC: C07D217/14
Filed: 1989-02-17
Abstract: A compound, or a solvate or salt thereof, of formula (I): <CHEM>  in which: RCO is an acyl group in which the group R contains a substituted or unsubstituted carbocyclic aromatic or heterocyclic aromatic ring and R1 and R2 are independently hydrogen, C1-6 alkyl, C2-6 alkenyl, C3-6 cycloalkyl or C4-12 cycloalkylalkyl groups or together form a C2-8 branched or linear polymethylene or C2-6 alkenylene group optionally substituted with a hetero-atom; R3 is hydrogen, C1-6 alkyl, or phenyl, or R3 together with R1 forms a -(CH2)3- or -(CH2)4-, group; R4 and R5, which may be the same or different and may be attached to the same or different carbon atoms of the isoquinoline nucleus, are each hydrogen, halogen, hydroxy, C1-6 alkyl, aryl, or R4 together with R5 form a -(CH2)p- group, where p is an integer of from 1 to 5 and one or more of the -(CH2)- moieties is optionally substituted by a C1-6 alkyl group. R6 and R6a, which may be the same or different, are each hydrogen, C1-6 alkyl, -CH2OR6b, halogen, hydroxy, C1-6 alkoxy, C1-6 alkoxycarbonyl, thiol, C1-6 alkylthio,   -O @R6c, -NHCOR6d, -NHSO2R6e, -CH2SO2NR6fR6g, in which each of R6b to R6g is independently hydrogen, C1-6 alkyl, aryl or aralkyl; with the proviso that R4, R5, R6 and R6a are not simultaneously hydrogen, is useful for the treatment of pain. a
Patent IE-870784-L (IE)
Title: Compounds having a cognition adjuvant action
IPC: A61P25/28
Filed: 1987-03-26
Abstract: The invention relates to novel compounds having a nootropic activity, the use of ACE inhibitors as medicaments having nootropic activity, agents containing them, and their use in the treatment and prophylaxis of cognitive malfunctions.
Patent FI-851723-L (FI)
Inventor: AFCHAIN JEAN
IPC: B65D88/12
Filed: 1985-04-30
Abstract: 1. A container or large bucket for lorry, being particularly intended for the conditioning, storage and transport of powdered products in bulk, said container or large bucket (1) comprising concurrent lateral walls, such as the longitudinal walls (3, 4) and the bottom plates (2) defining between them the storage volume, said walls (2 to 4) being reinforced with cross-bars fastened to the lateral walls, such as the stiffening cross-bars (6) of the longitudinal walls (3, 4) and/or the reinforcement cross-bars (7) of the bottom plates (2), characterized in that it comprises one or several assembling sections (9 ; 10) disposed on the level with the edges of concurrence of two adjacent lateral walls (2, 3, 4), having a web (11) whose the longitudinal axis corresponds to said edge of concurrence, around which are distributed at least : a first wing (12) whose the plan is appreciably parallel with this of the first lateral wall, on which is fastened the latter, a second wing (13), integral with said first wing (12), whose the plan is appreciably parallel with this of the second lateral wall, on which is fastened the latter, a third wing (15 ; 16), integral with said first wing, whose the plan is transversely disposed with respect to said first wing (12), said first (12) and second (13) wings having means (17, 18) for positioning the sheet-metals constituting the concurrent lateral walls (2, 3, 4) suitable for positioning the respective edges of the sheet-metals with respect to the edge of concurrence, said first (12) and third (15 ; 16) wings substantially constituting the means for positioning the cross-bars (6, 7) suitable for positioning the ends of the stiffening cross-bars (6) and the reinforcement cross-bars (7).
Patent IE-881410-L (IE)
Title: Anticoccidial composition
IPC: A61K31/35
Filed: 1988-05-10
Abstract: Compositions comprising a mixture of the antibiotic frenolicin B or a pharmaceutically acceptable salt or ester thereof with one of the ionophorous polyether anticoccidial agents or a pharmaceutically acceptable salt or ester thereof, useful for the treatment and prevention of coccidiosis in animals, and methods of preventing or combatting coccidiosis are described.
[EP0290998A2]
Patent IE-38456-L (IE)
Title: Tyres, separate tread and elastometic sidewalls
IPC: B60C11/01
Filed: 1973-10-16
Abstract: In the parent patent tyre has two sidewalls whose axis of the transverse section shows an inwardly directed convexity and a tread strip consisting of an annular rubber strip and an inextensible annular structure. In this addn. the tread strip, including the reinforcing structure is sepd. from the two sidewalls.
[IT1045035B]
Patent IE-801888-L (IE)
Title: Trans-fused decahydroquinolinol derivatives
IPC: C07D215/233
Filed: 1980-09-09
Abstract: Decahydroquinolinol derivatives corresponding to the general formula: <IMAGE> and pharmaceutically acceptable acid addition salts thereof, in which R1 represents hydrogen, a methyl, ethyl, n-propyl, n-butyl or phenyl radical or a phenyl radical having one substituent or two identical or different substituents selected from chlorine, bromine atoms and a methyl group. Ar represents a phenyl or naphthyl radical or a phenyl radical having one substituent or two identical or different substituents selected from fluorine, chlorine and bromine atoms and methyl, methoxy, acetyl and cyano groups, X represents oxygen or sulfur, n represents 2 or 3. They are useful as antiarrhthmic and local anaesthetic agents.
[US4332805A]
Patent IE-882249-L (IE)
Title: Polyethylene glycol carbamates
IPC: A61P25/28
Filed: 1988-07-22
Abstract: Compounds of the formula    <IMAGE>  (I)    <IMAGE>   in which R is alkyl having up to 4 carbon atoms, n has an average value of at least 9, X is a radical of the formula -C(=O)-(NH-SO2)m- in which m is 0 or 1 and, if m is 1, the carbonyl group may be bonded to the oxygen atom or to the nitrogen atom, and each of the radicals A1, A2 and A3, independently of the others, is hydrogen or an acyl radical, and salts of salt-forming compounds of formula I, as well as metal complexes of compounds of formula I, in which A1, A2 and A3 are hydrogen can be used as metal chelators and as auxiliaries in diagnosis.
Patent IE-882286-L (IE)
Title: Oral sustrained release acetaminophen formulation and process
IPC: A61K9/20
Filed: 1988-07-26
Abstract: An acetaminophen-sustained release tablet or tablet layer is formed by making a wet granulation, using Povidone (PVP) in water or alcohol-water as the granulating fluid which is mixed with acetaminophen, hydroxyethyl cellulose, a wicking agent e.g. microcrystalline cellulose, then drying and milling the granulation and blending with dry powdered erosion promoter, e.g. pregelatinized starch, wicking agent, lubricant e.g. magnesium stearate and glidant e.g. silicon dioxide, and compressing the resultant granulation, which upon administration results in a slow release of the acetaminophen.
[EP0305051A1]
Patent IE-883041-L (IE)
Title: Fluidized-bed process and apparatus for purification of¹waste water
IPC: B01J8/00
Filed: 1988-10-07
Abstract: The present invention relates to a process for the anaerobic purification of waste water which comprises a fluidized-bed process in which granular sludge is applied. Moreover apparatus is disclosed for the purification of waste water using a fluidized-bed reactor wherein a liquid introduction device is present which is formed by one or more separate inlet pipes, the pipes delivering the liquid near the bottom of the reactor with an outlet velocity of 0.5-4 m/s, preferably 1-2 m/s.
[EP0311215A1]
Patent IE-893596-L (IE)
Title: Pharmaceutical aqueous solution for ophthalmic use¹comprising a water soluble pharmaceutically acceptable acid¹addition salt of ibopamine
IPC: A61K9/00
Filed: 1989-11-08
Abstract: The solution is buffered at pH 4.5 and comprises from 0.1 to 0.5 parts by weight of hydroxy propyl methyl cellulose for each part by weight of a water soluble pharmaceutically acceptable acid addition salt of ibopamine.
[WO9004964A1]
Patent NO-763401-L (NO)
Title: Reguleringsanordning.
Inventor: AYLWARD CONRAD JOHN
IPC: H03H7/40
Filed: 1976-10-05
Abstract: " Regaleringsanordning?